Gene · 1666
Papers3,981
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,981
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oxidative stress, free radicals and antioxidants: potential crosstalk in the pathophysiology of human diseases. | Front Chem | 2023 | 37234200 | PubTator, text mining | PubMed |
| Thioredoxin1 is a target to attenuate diabetes‑induced RPE cell dysfunction in human ARPE19 cells by alleviating oxidative stress. | Mol Med Rep | 2023 | 37232340 | PubTator, text mining | PubMed |
| The epigenetic regulatory mechanisms of ferroptosis and its implications for biological processes and diseases. | MedComm (2020) | 2023 | 37229485 | PubTator, text mining | PubMed |
| Proanthocyanidins: A novel approach to Henoch‑Schonlein purpura through balancing immunity and arresting oxidative stress via TLR4/MyD88/NF‑κB signaling pathway (Review). | Exp Ther Med | 2023 | 37229322 | PubTator, text mining | PubMed |
| Pathophysiological role of BACH transcription factors in digestive system diseases. | Front Physiol | 2023 | 37228820 | PubTator, text mining | PubMed |
| Gene expression signature predicts rate of type 1 diabetes progression. | EBioMedicine | 2023 | 37224769 | PubTator, text mining | PubMed |
| Drug-induced oxidative stress in cancer treatments: Angel or devil? | Redox Biol | 2023 | 37224697 | PubTator, text mining | PubMed |
| Comprehensive analysis and identification of prognostic biomarkers and immunotherapeutic targets in the NADPH oxidase family (and its regulatory subunits) in pancreatic ductal adenocarcinoma. | Clin Transl Oncol | 2023 | 37222951 | PubTator, text mining | PubMed |
| New insights into lipid metabolism and prostate cancer (Review). | Int J Oncol | 2023 | 37203395 | PubTator, text mining | PubMed |
| Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment. | Adv Nutr | 2023 | 37187454 | PubTator, text mining | PubMed |
| Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery. | Front Pharmacol | 2023 | 37180709 | PubTator, text mining | PubMed |
| Immunomodulatory role of estrogen in ischemic stroke: neuroinflammation and effect of sex. | Front Immunol | 2023 | 37180115 | PubTator, text mining | PubMed |
| Cure of Alzheimer's Dementia in Many Patients by Using Intranasal Insulin to Augment an Inadequate Counter-Reaction, Edaravone to Scavenge ROS, and 1 or 2 Other Drugs to Address Affected Brain Cells. | J Clin Med | 2023 | 37176592 | PubTator, text mining | PubMed |
| KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression. | Front Cell Dev Biol | 2023 | 37152291 | PubTator, text mining | PubMed |
| NETosis as an oncologic therapeutic target: a mini review. | Front Immunol | 2023 | 37143649 | PubTator, text mining | PubMed |
| Structure-guided semi-rational design of an imine reductase for enantio-complementary synthesis of pyrrolidinamine. | Chem Sci | 2023 | 37123194 | PubTator, text mining | PubMed |
| COVID-19 in Cyanotic Congenital Heart Disease. | Can J Infect Dis Med Microbiol | 2023 | 37114013 | PubTator, text mining | PubMed |
| Diverse Biological Activity of Benzofuroxan/Sterically Hindered Phenols Hybrids. | Pharmaceuticals (Basel) | 2023 | 37111256 | PubTator, text mining | PubMed |
| Synthesis of Novel 2-(Cyclopentylamino)thiazol-4(5H)-one Derivatives with Potential Anticancer, Antioxidant, and 11β-HSD Inhibitory Activities. | Int J Mol Sci | 2023 | 37108415 | PubTator, text mining | PubMed |
| Proteomic Analysis of Arsenic Resistance during Cyanide Assimilation by Pseudomonas pseudoalcaligenes CECT 5344. | Int J Mol Sci | 2023 | 37108394 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1666/papers?page=16